ELUCIDATING THE MECHANISM OF RECEPTOR TYROSINE KINASE INHIBITION BY SOLUBLE LRIG1 IN GLIOBLASTOMA

被引：0
|
作者：
Tiemann, Katja [1 ]
Hedman, Hakan [2 ]
Niclou, Simone P. [1 ]
机构：
[1] CRP Sante, NorLux Neurooncol Lab, Dept Oncol, Luxembourg, Luxembourg
[2] Umea Univ, Dept Radiat Sci, Umea, Sweden
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [1] Endogenous Inhibitors of Tyrosine Kinase Receptors - a Therapeutic Role for Soluble LRIG1 in Malignant Glioma?
    Tiemann, K.
    Bernard, A.
    Fack, F.
    Johansson, M.
    Hedman, H.
    Niclou, S. P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S152 - S152
  • [2] HARNESSING SOLUBLE LRIG1 FOR PAN-RTK TARGETING IN GLIOBLASTOMA
    Neirinckx, V.
    Schuster, A.
    Chevigne, A.
    Schmidt, M. H. H.
    Niclou, S. P.
    NEURO-ONCOLOGY, 2018, 20 : 218 - 218
  • [3] Lrig1 is an endogenous inhibitor of ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF
    Ledda, Fernanda
    Bieraugel, Oliver
    Fard, Shahrzad Shirazi
    Vilar, Marcal
    Paratcha, Gustavo
    JOURNAL OF NEUROSCIENCE, 2008, 28 (01): : 39 - 49
  • [4] LRIG1 Improves Chemosensitivity Through Inhibition of BCL-2 and MnSOD in Glioblastoma
    Jianjun Ding
    Baohui Liu
    Yi He
    Xianhou Yuan
    Daofeng Tian
    Baowei Ji
    Long Wang
    Liquan Wu
    Huimin Dong
    Junmin Wang
    Xiaonan Zhu
    Qiang Cai
    Shenqi Zhang
    Qianxue Chen
    Cell Biochemistry and Biophysics, 2015, 71 : 27 - 33
  • [5] LRIG1 Improves Chemosensitivity Through Inhibition of BCL-2 and MnSOD in Glioblastoma
    Ding, Jianjun
    Liu, Baohui
    He, Yi
    Yuan, Xianhou
    Tian, Daofeng
    Ji, Baowei
    Wang, Long
    Wu, Liquan
    Dong, Huimin
    Wang, Junmin
    Zhu, Xiaonan
    Cai, Qiang
    Zhang, Shenqi
    Chen, Qianxue
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (01) : 27 - 33
  • [6] LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells
    Guo, Zhentao
    Chen, Qianxue
    Liu, Baohui
    Tian, Daofeng
    Zhang, Shenqi
    Li, Mingchang
    YONSEI MEDICAL JOURNAL, 2014, 55 (05) : 1196 - 1205
  • [7] LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNFα Expression and Receptor Tyrosine Kinase Signaling
    Bai, Longchuan
    McEachern, Donna
    Yang, Chao-Yie
    Lu, Jianfeng
    Sun, Haiying
    Wang, Shaomeng
    CANCER RESEARCH, 2012, 72 (05) : 1229 - 1238
  • [8] The transmembrane protein LRIG1 regulates receptor tyrosine kinases in skin development and homeostasis
    Hoesl, C.
    Wolf, R.
    Wolf, E.
    Schneider, M.
    Dahlhoff, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S206 - S206
  • [9] Soluble LRIG1 inhibits cancer cell growth
    Goldoni, S.
    Iozzo, R.
    Kay, P.
    Campbell, S.
    McQuillan, A.
    Agnew, C.
    Zhu, J.
    Keen, D.
    Reed, C.
    Iozzo, R.
    MATRIX BIOLOGY, 2006, 25 : S40 - S41
  • [10] Lrig1 regulates the balance between proliferation and quiescence in glioblastoma stem cells
    Ferguson, Kirsty M.
    Blin, Carla
    Alfazema, Neza
    Gangoso, Ester
    Pollard, Steven M.
    Angeles Marques-Torrejon, Maria
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
12345